2 withdrawn, 1 not yet recruiting. 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Vishal Jhanji: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluorometholone Study Adjunctive Topical Fluorometholone (FML) 0.1%, Standard Topical Antibiotic Therapy - Keratitis Bacterial, Corneal Ulcer (Diagnosis) | Phase 2 | Not yet recruiting | Vishal Jhanji | 174 | 2026-10-31 | 2026-06-10 |
| Tear Film Markers in Dry Eye Syndrome Cyclosporine, Artificial tear - Dry Eye | Phase 4 | Withdrawn | Vishal Jhanji | 2023-12-08 | 2023-12-18 | |
| PXL-Platinum 330 in Eyes With Corneal Thinning Conditions Pulsed or continuous lighting - Corneal Thinning, Keratoconus | Phase 1 / Phase 2 | Withdrawn | Vishal Jhanji | 2023-08-15 | 2023-10-05 |
Corneal Ulcer (1) · Disease (1) · Dry Eye Syndromes (1) · Keratoconus (1)
Cyclosporine (1) · Cyclosporins (1) · Fluorometholone (1) · Heart Rate (1) · Lubricant Eye Drops (1)
United States (3)